Presepsin is a biomarker that can predict mortality in sepsis patients
Open Access
- 1 January 2025
- journal article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (2) , e20241262
Abstract
SUMMARY OBJECTIVE: Predicting the prognosis of sepsis, a major health problem worldwide, is vital to guide the treatment process accordingly. The aim of this study was to evaluate the ability of presepsin levels to predict mortality in patients with sepsis. METHODS: The study included 87 intensive care unit patients with sepsis, 30 of whom survived. Complete blood count, blood gas, C-reactive protein, procalcitonin, albumin, and presepsin levels were analyzed. Binary logistic regression and receiver operating characteristic analyses were performed for presepsin levels. RESULTS: Presepsin levels were higher in non-survivors than in survivors. There was no significant difference in other laboratory parameters. The predictive value of presepsin level on mortality was found to be 78.20%. The cutoff value in the receiver operating characteristic curve graph for presepsin levels is 612.70 pg/mL. The positive predictive value of presepsin levels in terms of mortality is 0.5735, and the negative predictive value is 0.8512. The sensitivity of presepsin levels in terms of mortality is 73.70%, and the specificity is 73.30%. The area under the curve value in the receiver operating characteristic curve plot for mortality for presepsin levels is 0.819. CONCLUSION: Presepsin levels may predict mortality in patients with sepsis. Presepsin levels above the cutoff value of 612.70 pg/mL may be considered a risk factor for mortality in patients with sepsis.Keywords
This publication has 24 references indexed in Scilit:
- Presepsin as a biomarker in perioperative medicineMinerva Anestesiologica, 2020
- Sepsis diagnosis and monitoring – procalcitonin as standard, but what next?Anaesthesiology Intensive Therapy, 2019
- The neutrophil-lymphocyte count ratio as a diagnostic marker for bacteraemia: A systematic review and meta-analysisThe American Journal of Emergency Medicine, 2019
- Presepsin As a Biomarker for Evaluating Prognosis and Early Innate Immune Response of Out-of-Hospital Cardiac Arrest Patients After Return of Spontaneous CirculationCritical Care Medicine, 2019
- Presepsin: A promising biomarker for the detection of bacterial infectionsBiomedicine & Pharmacotherapy, 2019
- Increased presepsin levels are associated with the severity of fungal bloodstream infectionsPLOS ONE, 2018
- Sepsis 2018: Definitions and Guideline ChangesSurgical Infections, 2018
- Sepsis: A Review of Advances in ManagementAdvances in Therapy, 2017
- Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell lineAnnales de biologie clinique, 2016
- Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndromeJournal of Infection and Chemotherapy, 2011